Prothena Corporation plc (PRTA) Financial Statements (2024 and earlier)

Company Profile

Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
DUBLIN 2, D02 VK60
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments710,406579,094295,380375,723427,659417,620
Cash and cash equivalents710,406579,094295,380375,723427,659417,620
Restricted cash and investments  1,352   
Receivables  15682240
Prepaid expense1,708     
Other current assets    2,584  
Other undisclosed current assets6,9845,7152,537 3,7298,467
Total current assets:719,098584,809299,284378,375431,390426,327
Noncurrent Assets
Operating lease, right-of-use asset6,27712,12317,81123,274
Property, plant and equipment1,7312,0122,5513,87452,83554,990
Restricted cash and investments2,2121,3521,3522,704 4,056
Deferred income tax assets18,2047,07111,644 
Other noncurrent assets10,5131,9993331,0858132,843
Other undisclosed noncurrent assets    9,95613,7588,113
Total noncurrent assets:38,93724,55733,69140,89367,40670,002
TOTAL ASSETS:758,035609,366332,975419,268498,796496,329
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,2703,6914,1531,2471,52413,944
Taxes payable 36554311
Accounts payable9,2703,6914,1171,2421,47013,633
Deferred revenue 11,4427,657  
Debt    5,101  
Restructuring reserve     461 
Other liabilities12,1689,8137,1395,5405,9269,185
Other undisclosed current liabilities17,26712,29114,5565,8267,01514,242
Total current liabilities:50,14733,45225,84817,71414,92637,371
Noncurrent Liabilities
Long-term debt and lease obligation:  6,38612,32617,838  
Liabilities, other than long-term debt85,846103,486110,795110,795729254
Deferred revenue and credits254
Deferred revenue85,293102,933110,242110,242
Deferred rent credit     176
Other liabilities 553553553553553 
Operating lease, liability 6,38612,32617,838
Other undisclosed noncurrent liabilities     160,14351,515
Total noncurrent liabilities:85,846109,872123,121128,633160,87251,769
Total liabilities:135,993143,324148,969146,347175,79889,140
Equity
Equity, attributable to parent622,042466,042184,006272,921322,998407,189
Common stock521466399399399385
Additional paid in capital1,454,5241,181,630966,636944,407920,594849,154
Accumulated deficit(833,003)(716,054)(783,029)(671,885)(597,995)(442,350)
Total equity:622,042466,042184,006272,921322,998407,189
TOTAL LIABILITIES AND EQUITY:758,035609,366332,975419,268498,796496,329

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues53,905200,5772,90081495527,519
Sublease income2,9002,9002,9002,900
Gross profit:53,905200,5772,90081495527,519
Operating expenses(185,462)(128,602)(113,587)(86,511)(159,810)(182,773)
Other undisclosed operating loss   (2,047)   
Operating income (loss):(131,557)71,975(112,734)(85,697)(158,855)(155,254)
Nonoperating income (expense)5,952(54)1,3078,3992,740(2,349)
Other nonoperating income (expense)(397)(96)(62)19648(2,207)
Income (loss) from continuing operations before income taxes:(125,605)71,921(111,427)(77,298)(156,115)(157,603)
Income tax expense (benefit)8,656(4,946)283(379)4704,366
Income (loss) from continuing operations:(116,949)66,975(111,144)(77,677)(155,645)(153,237)
Income (loss) before gain (loss) on sale of properties:66,975(111,144)(77,677)(155,645)(153,237)
Net income (loss) available to common stockholders, diluted:(116,949)66,975(111,144)(77,677)(155,645)(153,237)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(116,949)66,975(111,144)(77,677)(155,645)(153,237)
Comprehensive income (loss), net of tax, attributable to parent:(116,949)66,975(111,144)(77,677)(155,645)(153,237)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: